ClinicalTrials.gg
RecruitingNCT07001111Updated Sep 12, 2025

Investigation of the Effectiveness of Kinesiological Taping in Cubital Tunnel Syndrome

An interventional study of kinesio taping and Ulnar nerve mobilization exercise in Cubital Tunnel Syndrome, Kinesio Taping and Ulnar Neuropathies, sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-09-12.

Sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to investigate the effect of kinesiological taping, applied in addition to exercise, on clinical symptoms in patients diagnosed with Cubital Tunnel Syndrome. The patients will be randomized into three groups (exercise, exercise + kinesiological taping, exercise + sham taping) and will be evaluated at the 1st and 3rd months after a 3-week treatment period.

Read the detailed description

Cubital Tunnel Syndrome (CuTS), characterized by the compression of the ulnar nerve at the elbow, is a condition that causes symptoms such as pain, numbness, paresthesia, and muscle weakness in the affected limb. Ulnar nerve compression is the second most common entrapment neuropathy after median nerve entrapment . The ulnar nerve can become compressed at various locations, including the elbow and wrist. The nerve is formed by the C8 and T1 spinal nerve roots, which make up the lower trunk and medial cord of the brachial plexus. It travels along the medial aspect of the humerus, passes through Struthers' arcade, the retro-epicondylar groove, and enters the cubital tunnel. The roof of the cubital tunnel is known as the cubital tunnel retinaculum. The ulnar nerve then passes beneath the aponeurosis of the flexor carpi ulnaris muscle and its two heads, where the upper edge of the aponeurosis forms the Osborne ligament, which is likely the most commonly affected area in ulnar nerve entrapment. In the forearm, the ulnar nerve is located beneath the flexor carpi ulnaris muscle and innervates this muscle along with the ulnar half of the flexor digitorum profundus muscle. The nerve then proceeds toward Guyon's canal along with the ulnar artery. Distally, the nerve branches into three divisions: the dorsal sensory branch, the volar superficial sensory branch, and the deep motor branch. The deep motor branch descends into the deep part of the hand beneath the edge of the aponeurosis surrounding the hook of the hamate bone, innervating most of the hypothenar and intrinsic muscles. The dorsal sensory branch leaves the main trunk approximately 5-8 cm proximal to Guyon's canal and innervates the dorsal ulnar portion of the hand .

In patients with Cubital Tunnel Syndrome, pain, numbness, paresthesia in the 4th and 5th fingers, and in advanced stages, muscle weakness leading to atrophy of the hypothenar muscles and claw hand deformity may be observed. The diagnosis is made through electrophysiological studies (EMG/NCS).

Treatment options include both conservative and surgical approaches. Surgical options include cubital tunnel decompression, medial epicondylectomy, and ulnar nerve transposition . Surgical treatment is generally preferred for patients with muscle weakness and atrophy, as well as those who do not respond to conservative treatments. Conservative treatment options include avoiding positions of the elbow that may exacerbate symptoms, splinting, exercise, electrotherapy, and local steroid injections .

Kinesiotaping, developed by chiropractor and acupuncturist Kenzo Kase in the late 1970s, is a commonly used conservative treatment option for musculoskeletal pathologies in physical therapy clinics. The tape is made of cotton, stretches longitudinally up to 40%, is water-resistant, and can stay on the skin for up to 7 days.

Kinesiotaping is believed to support muscles, correct joint movement, enhance blood and lymph circulation, provide proprioceptive input, and reduce pain and muscle spasms . Various physical therapy modalities, steroid injections, and dry needling have been studied for their effects on Cubital Tunnel Syndrome. Kinesiotaping has been shown to be effective in patients with Carpal Tunnel Syndrome. However, there is no study available on the use of kinesiotaping in CuTS patients. This simple, cost-effective treatment modality, commonly used in physical therapy practice for various pathologies, will be investigated for its efficacy in patients with Cubital Tunnel Syndrome.

02

Conditions studied

  • Cubital Tunnel Syndrome
  • Kinesio Taping
  • Ulnar Neuropathies

Keywords

  • Cubital Tunnel Syndrome
  • Kinesio taping
  • ulnar neuropathies
03

In context

Cubital Tunnel Syndrome

35 studies on the registry are indexed under Cubital Tunnel Syndrome; 6 are open to participants now.

This study's planned enrollment of 36 is below the median of 65 across 25 interventional studies indexed under Cubital Tunnel Syndrome.

Browse Cubital Tunnel Syndrome studies →

Lead sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey is the lead sponsor of 108 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 65 years
  • Patients with at least 3 points of pain according to the Numeric Rating Scale (NRS)
  • Patients diagnosed with Cubital Tunnel Syndrome via Electroneuromyography (ENMG)
  • Literate
  • Willing to consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Having any secondary entrapment neuropathy such as diabetes, inflammatory arthritis, or hypothyroidism
  • Pregnancy
  • Active cancer presence
  • Skin infection, burns, wounds, or scars on the forearm
  • History of elbow trauma
  • Cervical radiculopathy or brachial plexopathy
  • Polyneuropathy
  • Having previously undergone Cubital Tunnel decompression surgery
  • Having received a injection into the Cubital Tunnel within the last 3 months
  • Illiterate
  • Not consenting to participate in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
36 participants (estimated)

Study arms

  • Other
    Control

    All patients will be provided with information and an exercise sheet containing pictures on ulnar nerve gliding exercises. To monitor whether patients are performing the exercises correctly, they will be asked to come to the hospital once a week, where they will perform the exercises under the supervision of a physiotherapist. In the exercise program, different positions will be held for 30 seconds, with a 1-minute rest between them, and the exercises will be performed twice a day .

    Other: Ulnar nerve mobilization exercise · Diagnostic Test: Numeric Rating Scale (NRS) · Diagnostic Test: the ulnar nerve cross-sectional area measured by ultrasound · Diagnostic Test: Neuropathic pain scale (measured using the DN-4 scale) · Diagnostic Test: SF-12 Quality of Life Scale · Diagnostic Test: QUICK-DASH · Diagnostic Test: Grip strength measured with a hand dynamometer

  • Active comparator
    Kinesio Taping

    It will be applied once a week for 3 weeks to the affected elbow by an experienced practitioner. During taping, the space correction technique will be used. In this technique, the kinesiological tape is applied with a hole cut in the center, slightly larger than the area to be treated .

    Other: kinesio taping · Other: Ulnar nerve mobilization exercise · Diagnostic Test: Numeric Rating Scale (NRS) · Diagnostic Test: the ulnar nerve cross-sectional area measured by ultrasound · Diagnostic Test: Neuropathic pain scale (measured using the DN-4 scale) · Diagnostic Test: SF-12 Quality of Life Scale · Diagnostic Test: QUICK-DASH · Diagnostic Test: Grip strength measured with a hand dynamometer

  • Sham comparator
    Sham Taping

    It will be applied in the same way as kinesiological taping with adhesive tape.

    Other: Ulnar nerve mobilization exercise · Other: Sham (No Treatment) · Diagnostic Test: Numeric Rating Scale (NRS) · Diagnostic Test: the ulnar nerve cross-sectional area measured by ultrasound · Diagnostic Test: Neuropathic pain scale (measured using the DN-4 scale) · Diagnostic Test: SF-12 Quality of Life Scale · Diagnostic Test: QUICK-DASH · Diagnostic Test: Grip strength measured with a hand dynamometer

Interventions

  • Otherkinesio taping

    Kinesio taping at the level of the cubital tunnel on the elbow

  • OtherUlnar nerve mobilization exercise

    All patients will be provided with information and an exercise sheet containing pictures on ulnar nerve gliding exercises. To monitor whether patients are performing the exercises correctly, they will be asked to come to the hospital once a week, where they will perform the exercises under the supervision of a physiotherapist. In the exercise program, different positions will be held for 30 seconds, with a 1-minute rest between them, and the exercises will be performed twice a day .

  • OtherSham (No Treatment)

    It will be applied in the same way as kinesiological taping with adhesive tape.

  • Diagnostic testNumeric Rating Scale (NRS)

    Description: To demonstrate that kinesiological taping will result in a reduction of pain intensity associated with Cubital Tunnel Syndrome, as measured by the Numeric Rating Scale (NRS) ranging from 0 to 10.

  • Diagnostic testthe ulnar nerve cross-sectional area measured by ultrasound

    The measurements will be taken with the patient in a supine position, the affected arm in shoulder abduction and external rotation, and the elbow flexed at 70°-90°. After applying a generous amount of gel, the lateral edge of the ultrasound probe will be placed on the medial epicondyle, and the medial edge of the probe will be positioned on the olecranon; the ulnar nerve will be directly examined in the retroepicondylar groove. Once the nerve is visualized, the widest point will be identified, and cross-sectional area (CSA) measurements will be taken with the probe perpendicular to the nerve at the center of the screen . The measurements will be repeated twice, and the average will be calculated.

  • Diagnostic testNeuropathic pain scale (measured using the DN-4 scale)

    The DN4 questionnaire consists of two main sections and a total of ten questions. The first section includes seven questions related to pain characteristics and sensory information obtained through patient interview. These questions are about burning, electric shocks, coldness, tingling, pricking, numbness, and itching. The second section contains three statements related to physical examination (touch hypoesthesia, pinprick hypoesthesia, and allodynia). For each statement, "yes" or "no" responses are given. A score of "1" is assigned for "yes" answers and "0" for "no" answers, and the scores are summed. A total score of 4 or more out of 12 is interpreted as neuropathic pain.

  • Diagnostic testSF-12 Quality of Life Scale

    The SF-12 Quality of Life Scale is a short form of the SF-36 Quality of Life Scale. While the SF-36 is used for chronic conditions (states), the SF-12 is used for short-term assessments (clinical findings). Similarly, it is also used to gather information about the patient's general health status. The SF-12 provides the same summary component scores as the SF-36, but with fewer items, making it a significant advantage due to its shorter application time. The scale asks the patient about their health opinions, how they feel, and how easily they can perform their usual activities. Scores range from 0 to 100, with higher scores indicating better quality of life.

  • Diagnostic testQUICK-DASH

    QUICK-DASH (Shoulder, Arm, and Hand Problems Questionnaire): This questionnaire assesses both the ability to perform certain physical activities as well as the symptoms of the disease. Each question is answered based on the condition of the past week, and the appropriate score is marked. The answer is given based solely on the ability to perform the physical activity, without considering which hand or arm is injured. Scoring: 1. = No difficulty 2. = Mild difficulty 3. = Moderate difficulty 4. = Severe difficulty 5. = Unable to perform QUICK DASH DISABILITY/SYMPTOM SCORE: (\[(n total score\] - 1) x 25; where n represents the number of questions answered. If more than one question is unanswered, the Quick DASH score cannot be calculated. SCORE FOR OPTIONAL MODELS: For each model, divide the total score by 4, subtract 1, and multiply by 25. If more than one question is unanswered, the score for optional models cannot be calculated. Based on the results of the questionnaire, a score b

  • Diagnostic testGrip strength measured with a hand dynamometer

    Grip strength will be measured using a hand dynamometer, with the average of three measurements taken, each followed by a 30-second rest period.

06

What researchers measure

Primary outcomes

  1. Numeric Rating Scale (NRS)

    To demonstrate that kinesiological taping will result in a reduction of pain intensity associated with Cubital Tunnel Syndrome, as measured by the Numeric Rating Scale (NRS) ranging from 0 to 10.

    Time frame: 3 months

Secondary outcomes

  1. the ulnar nerve cross-sectional area measured by ultrasound

    The measurements will be taken with the patient in a supine position, the affected arm in shoulder abduction and external rotation, and the elbow flexed at 70°-90°. After applying a generous amount of gel, the lateral edge of the ultrasound probe will be placed on the medial epicondyle, and the medial edge of the probe will be positioned on the olecranon; the ulnar nerve will be directly examined in the retroepicondylar groove. Once the nerve is visualized, the widest point will be identified, and cross-sectional area (CSA) measurements will be taken with the probe perpendicular to the nerve at the center of the screen . The measurements will be repeated twice, and the average will be calculated.

    Time frame: 3 months

  2. Neuropathic pain scale (measured using the DN-4 scale

    The DN4 questionnaire consists of two main sections and a total of ten questions. The first section includes seven questions related to pain characteristics and sensory information obtained through patient interview. These questions are about burning, electric shocks, coldness, tingling, pricking, numbness, and itching. The second section contains three statements related to physical examination (touch hypoesthesia, pinprick hypoesthesia, and allodynia). For each statement, "yes" or "no" responses are given. A score of "1" is assigned for "yes" answers and "0" for "no" answers, and the scores are summed. A total score of 4 or more out of 12 is interpreted as neuropathic pain.

    Time frame: 3 months

  3. SF-12 Quality of Life Scale

    The SF-12 Quality of Life Scale is a short form of the SF-36 Quality of Life Scale. While the SF-36 is used for chronic conditions (states), the SF-12 is used for short-term assessments (clinical findings). Similarly, it is also used to gather information about the patient's general health status. The SF-12 provides the same summary component scores as the SF-36, but with fewer items, making it a significant advantage due to its shorter application time. The scale asks the patient about their health opinions, how they feel, and how easily they can perform their usual activities. Scores range from 0 to 100, with higher scores indicating better quality of life.

    Time frame: 3 months

  4. QUICK-DASH

    QUICK-DASH (Shoulder, Arm, and Hand Problems Questionnaire): This questionnaire assesses both the ability to perform certain physical activities as well as the symptoms of the disease. Each question is answered based on the condition of the past week, and the appropriate score is marked. The answer is given based solely on the ability to perform the physical activity, without considering which hand or arm is injured. Scoring: 1. = No difficulty 2. = Mild difficulty 3. = Moderate difficulty 4. = Severe difficulty 5. = Unable to perform QUICK DASH DISABILITY/SYMPTOM SCORE: (\[(n total score\] - 1) x 25; where n represents the number of questions answered. If more than one question is unanswered, the Quick DASH score cannot be calculated. SCORE FOR OPTIONAL MODELS: For each model, divide the total score by 4, subtract 1, and multiply by 25. If more than one question is unanswered, the score for optional models cannot be calculated. Based on the results of the questionnaire, a score b

    Time frame: 3 months

  5. Grip strength measured with a hand dynamometer

    Grip strength will be measured using a hand dynamometer, with the average of three measurements taken, each followed by a 30-second rest period.

    Time frame: 3 months

07

Study locations

1 of 2 sites recruiting
  • Health Sciences University
    Istanbul, Uskudar 34100, Turkey (Türkiye)
    Not yet recruiting
    • Aysu Girgin Güleşen · Contact
  • Sultan 2. Abdülhamid Han Eğitim ve Araştırma Hastanesi
    Istanbul, Üsküdar 34668, Turkey (Türkiye)
    Recruiting
    • Sultan 2. Abdülhamid Han Eğitim ve Araştırma Hastanesi · Contactdraysugirgin@gmail.com · +90(216) 542 2020
08

References and documents

Publications

  • Stewart JD. The variable clinical manifestations of ulnar neuropathies at the elbow. J Neurol Neurosurg Psychiatry. 1987 Mar;50(3):252-8. doi: 10.1136/jnnp.50.3.252. PubMed 3031220 ↗

Individual participant data

Plan to share: No — Data sharing not planned

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Nov 2025, 7 months after the start.

Of 15 interventional studies with no phase under Cubital Tunnel Syndrome, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 48. This study's planned 7 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2025
First posted
Jun 3, 2025
StartActual
Apr 21, 2025
Primary completionEst.
Nov 2025
CompletionEst.
Feb 2026
Last update
Sep 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07001111
Responsible party
Feyza Nur Yucel (Principal Investigator, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey) — Principal investigator
First posted
Jun 3, 2025
Start date
Apr 21, 2025
Primary completion
Nov 2025 (estimated)
Completion
Feb 2026 (estimated)
Last update
Sep 12, 2025

Study contacts

Aysu Girgin Gulesen
Contact
draysugirgin@gmail.com
(0216) 542 20 00 ext. +90
Feyza Nur Yücel, Specialist
Contact
dr.fny28@gmail.com
(0216) 542 20 00 ext. +90

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion